![Diagnostics | Free Full-Text | [68Ga]Ga-NODAGA-E[(cRGDyK)]2 and [64Cu]Cu-DOTATATE PET Predict Improvement in Ischemic Cardiomyopathy Diagnostics | Free Full-Text | [68Ga]Ga-NODAGA-E[(cRGDyK)]2 and [64Cu]Cu-DOTATATE PET Predict Improvement in Ischemic Cardiomyopathy](https://www.mdpi.com/diagnostics/diagnostics-13-00268/article_deploy/html/images/diagnostics-13-00268-g003.png)
Diagnostics | Free Full-Text | [68Ga]Ga-NODAGA-E[(cRGDyK)]2 and [64Cu]Cu-DOTATATE PET Predict Improvement in Ischemic Cardiomyopathy
![First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic | Journal of Nuclear Medicine First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/63/12/1871/F3.large.jpg)
First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic | Journal of Nuclear Medicine
Eske Rygaard-Hjalsted on LinkedIn: Minerva is looking for new colleagues, come join a great company on a…
![GE Healthcare & Minerva Imaging partner to accelerate targeted radionuclide therapy | GE HealthCare (Norway) GE Healthcare & Minerva Imaging partner to accelerate targeted radionuclide therapy | GE HealthCare (Norway)](https://images-cdn.welcomesoftware.com/Zz03Y2NlMTIzNDVlNGExMWVjYjhmYTNhMTc5NWQ4ODZkNg==/GE%20Healthcare%20and%20Minerva%20Imaging%20sign%20strategic%20partnership.jpeg)
GE Healthcare & Minerva Imaging partner to accelerate targeted radionuclide therapy | GE HealthCare (Norway)
![Site-Specific 64Cu Labeling of the Serine Protease, Active Site Inhibited Factor Seven Azide (FVIIai-N3), Using Copper Free Click Chemistry | Bioconjugate Chemistry Site-Specific 64Cu Labeling of the Serine Protease, Active Site Inhibited Factor Seven Azide (FVIIai-N3), Using Copper Free Click Chemistry | Bioconjugate Chemistry](https://pubs.acs.org/cms/10.1021/acs.bioconjchem.7b00649/asset/images/medium/bc-2017-00649b_0007.gif)
Site-Specific 64Cu Labeling of the Serine Protease, Active Site Inhibited Factor Seven Azide (FVIIai-N3), Using Copper Free Click Chemistry | Bioconjugate Chemistry
![Diagnostics | Free Full-Text | [68Ga]Ga-NODAGA-E[(cRGDyK)]2 and [64Cu]Cu-DOTATATE PET Predict Improvement in Ischemic Cardiomyopathy Diagnostics | Free Full-Text | [68Ga]Ga-NODAGA-E[(cRGDyK)]2 and [64Cu]Cu-DOTATATE PET Predict Improvement in Ischemic Cardiomyopathy](https://www.mdpi.com/diagnostics/diagnostics-13-00268/article_deploy/html/images/diagnostics-13-00268-g002.png)